Ripple Therapeutics | WebDisclosure

Basculer en Français

8396	Companies
122097	Keywords
60577	Articles
65553	Press releases

Home
Companies
Ripple Therapeutics

BRIEF

published on 10/15/2024 at 14:50, 2 months 6 days ago

Ripple Therapeutics Enters Agreements with Glaukos for Sustained Delivery Implants

Drug Delivery Licensing Agreements Ripple Therapeutics Glaukos Corporation Ophthalmic Therapeutics
BRIEF

published on 10/15/2024 at 14:50, 2 months 6 days ago

Ripple Therapeutics conclut des accords avec Glaukos pour des implants à libération prolongée

Accords De Licence Administration De Médicaments Thérapeutique Ripple Société Glaukos Thérapeutique Ophtalmique
PRESS RELEASE

published on 10/15/2024 at 14:45, 2 months 6 days ago

Ripple Therapeutics Announces Evaluation and Licensing Agreements with Glaukos
Ripple Therapeutics partners with Glaukos Corporation to develop sustained release implants for ophthalmic therapies, utilizing innovative drug delivery technology

Drug Delivery Technology Ripple Therapeutics Glaukos Corporation Ophthalmic Therapeutics Sustained Release Implants
BRIEF

published on 09/17/2024 at 14:35, 3 months 4 days ago

Ripple Therapeutics Announces Collaboration with AbbVie for Glaucoma Therapy Development

Partnership Drug Delivery Ophthalmology Glaucoma Therapy Biodegradable Implants
BRIEF

published on 09/17/2024 at 14:35, 3 months 4 days ago

Ripple Therapeutics annonce une collaboration avec AbbVie pour le développement d'un traitement contre le glaucome

Partenariat Ophtalmologie Traitement Du Glaucome Administration De Médicaments Implants Biodégradables
PRESS RELEASE

published on 09/17/2024 at 14:30, 3 months 4 days ago

Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management
AbbVie and Ripple collaborate to develop sustainable drug delivery implants for glaucoma treatment leveraging expertise and innovative technology

Glaucoma Drug Delivery AbbVie Ripple Implants

Accesswire

Published on 12/21/2024 at 01:30, 18 hours 5 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 18 hours 5 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 30 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours 35 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 20 hours 5 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

EQS Group

Published on 12/21/2024 at 00:51, 18 hours 44 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 50 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

Les Echos

Published on 12/21/2024 at 12:17, 7 hours 17 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 7 hours 17 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE